A new pan-nitinol occluder for transcatheter closure of ventricular septal defects in a canine model

Journal of Interventional Cardiology

Volumn 22, Issue 2, 2009, Pages 191-198

  Ding, Zhong Ru ^a,b   Qin, Yong Wen ^a   Hu, Jian Qiang ^a   Zhao, Xian Xian ^a   Yang, Zhi Hong ^a   Hong Wu, ^a   Cao, Jiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 94th Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVICE; DOG; HEART VENTRICLE SEPTUM DEFECT; INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAN NITINOL OCCLUDER; PRIORITY JOURNAL; THROMBOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ALLOYS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CHINA; DISEASE MODELS, ANIMAL; DOGS; ELECTROCARDIOGRAPHY; EUTHANASIA, ANIMAL; HEART SEPTAL DEFECTS, VENTRICULAR; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 64349098418     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00432.x     Document Type: Article

References (16)

1. Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Catheter Cardiovasc Interv 2002 56 : 508 515.
2. Carminati M, Butera G, Chessa M, et al. For the investigators of the European VSD Registry. Transcatheter closure of congenital ventricular septal defects: Results of the European Registry. Eur Heart J 2007 28 : 2361 2368.
3. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Results of the U.S. phase I trial. J Am Coll Cardiol 2006 47 : 319 325.
4. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. Cardiol Young 2007 17 : 243 253.
5. Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006 68 : 620 628.
6. Moor M, Abbag F, al Fadley F, et al. Thrombosis on the Rashkind double umbrella device: A complication of PDA occlusion. Cathet Cardiovasc Diagn 1996 38 : 186 188.
7. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004 Jan 21 43 : 302 309.
8. Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol 2004 93 : 426 431.
9. Delaney JW, Li JS, Rhodes JF. Major complications associated with transcatheter atrial septal occluder implantation: A review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis 2007 2 : 256 264.
10. Raghu A, Kawalsky D, Feldman M. Embolic stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device. Am J Cardiol 2006 98 : 1294 1296.
11. Willcoxson FE, Thomson JD, Gibbs JL. Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occluder with abciximab and heparin. Heart 2004 90 : e30.
12. Clarke AC, Hirsch KJ, Kells CM, et al. Thrombus formation on an atrial septal defect closure device. Can J Cardiol 2005 21 : 68 70.
13. Sherman JM, Hagler DJ, Cetta F. Thrombosis after septal closure device placement: A review of the current literature. Catheter Cardiovasc Interv 2004 63 : 486 489.
14. Hu JQ, Qin YW, Wang SQ, et al. Ventricular septal defect produced by transcatheter puncture for canine model experimental study. J Interv Radiol 2004 13 : 161 163 Chinese Z, Gu X, Berry JM, et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation 1999 20 (100 320 328.
15. Jiang SHL. Criterion should be emphasized on interventional therapy of congenital heart disease to prevent serious complication. The fourth salon of interventional therapy for congenital heart disease in china Available at http://www.365heart.com/meeting/xxb-gf/2007/index.shtml [Chinese]
16. Jiang SHL. Criterion should be emphasized on interventional therapy of congenital heart disease to prevent serious complication. Chin J Interv Cardiol 2007 15 : 301